Neurosoft Neuron-Spectrum-1 Technical Manual page 2

Neurosoft© 2020
5, Voronin str., Ivanovo, 153032, Russia
P.O. Box 10, Ivanovo, 153000, Russia
Phone: +7 (4932) 24-04-34 Fax: +7 (4932) 24-04-35
E-mail: com@neurosoft.ru Internet: www.neurosoft.ru
The digital systems Neuron-Spectrum-1, Neuron-Spectrum-2, Neuron-Spectrum-3, Neuron-Spectrum-4 and,
Neuron-Spectrum- 4/P, CloudEEG with Neuron-Spectrum.NET software are intended for use as digital
neurophysiological systems intended for recording, processing and display of biopotential signals such as
Electroencephalography (EEG) and long-latency Evoked Potential (EP). Polysomnography (PSG) derives from
Electroencephalography (EEG) by the means of a dedicated software module and dedicated electrodes.
The devices are portable and can register up to 8 (Neuron-Spectrum-1), 16 (Neuron-Spectrum-2), 19 (Neuron-
Spectrum-3), 21 (Neuron-Spectrum-4, Neuron-Spectrum-4/P, CloudEEG) EEG channels, 1 (Neuron-Spectrum-1,
Neuron-Spectrum-2, Neuron-Spectrum-3 and Neuron-Spectrum-4) or up to 4 polygraphic channels (Neuron-
Spectrum-4/P, CloudEEG: ECG, EOG), 1 respiratory channel and 2 direct current channels (Neuron-Spectrum-4/P).
Neuron-Spectrum.NET includes the Evoked potentials averaging function and Quantitative
electroencephalography (qEEG), including specific parameters such as Rhythmicity, FFT power ratio and
amplitude metrics.
The devices do not provide alarms, do not provide automated event marking and do not provide to the user any
diagnostic conclusion about the patient's condition. They are intended for use in the patient care institutions,
diagnostics centers, neurosurgical hospitals, experimental laboratories and sleep laboratories.
The patient group includes all ages and sexes.*
*Safety of use for this age group is confirmed by the results of clinical data.
Caution: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner